企業プロフィール
Thermo Fisher Scientific Inc 株価・ニュース・カタリスト
- ティッカー:
- TMO
- 取引所:
- NYSE
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
585.51 USD (-0.47%)
終値
最終更新: 2026年8月17日
179B USD
時価総額
株価変動の要因
As of Aug 17, 2026, TMO closed down 0.47% at $585.51. No new same-company headline was identified in the current news window.
企業概要
事業概要
Thermo Fisher Scientific is a life sciences tools and diagnostics company that supports drug discovery, clinical development, manufacturing, and laboratory workflows. Its role is foundational: it powers much of the biotech ecosystem without being a therapeutic developer itself.
所在地とセクター分類
Headquartered in the United States and listed on NYSE, Thermo Fisher has a global footprint across research, clinical, and industrial markets. It sits in life sciences tools and diagnostics rather than therapeutic biotech.
ビジネスモデルの特徴
The company generates revenue through instruments, consumables, services, and workflow solutions. Investors watch lab demand, biopharma spending, diagnostics activity, and the health of research budgets because they drive recurring usage across the platform.
バイオ業界での位置付け
Thermo Fisher sits at the infrastructure layer of biotech and pharma. It is less binary than drug-development names, but it is deeply tied to the industry’s overall spending cycle and research intensity.
今後のカタリスト
- Thermo Fisher’s next three months are mostly about bioprocess demand, clinical research spend, and whether biotech funding trends are finally turning from soft to stable. That readout matters because it decides whether the asset is ready for a larger and more expensive development step. If the data come in cleanly, the market tends to give the broader platform behind the program more credit.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。